Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?

SIMPLE SUMMARY: The treatment of hepatocellular carcinoma is burdened by an unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no adjuvant or neoadjuvant systemic therapy schemes have been validated for hepatocellular carcinoma to date. Perioperative combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nevola, Riccardo, Delle Femine, Augusto, Rosato, Valerio, Kondili, Loreta Anesti, Alfano, Maria, Mastrocinque, Davide, Imbriani, Simona, Perillo, Pasquale, Beccia, Domenico, Villani, Angela, Ruocco, Rachele, Criscuolo, Livio, La Montagna, Marco, Russo, Antonio, Marrone, Aldo, Sasso, Ferdinando Carlo, Marfella, Raffaele, Rinaldi, Luca, Esposito, Nicolino, Barberis, Giuseppe, Claar, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251995/
https://www.ncbi.nlm.nih.gov/pubmed/37296912
http://dx.doi.org/10.3390/cancers15112950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251995/
https://www.ncbi.nlm.nih.gov/pubmed/37296912
http://dx.doi.org/10.3390/cancers15112950

Ejemplares similares